|
LIN7C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03199999999826E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.404020E-04 |
| Normal-vs-Stage2 |
1.734390E-02 |
| Normal-vs-Stage3 |
3.79220000001901E-06 |
| Normal-vs-Stage4 |
8.57960000044677E-07 |
| Stage1-vs-Stage2 |
2.461800E-01 |
| Stage1-vs-Stage3 |
7.973800E-02 |
| Stage1-vs-Stage4 |
1.000300E-02 |
| Stage2-vs-Stage3 |
2.905600E-02 |
| Stage2-vs-Stage4 |
6.101100E-03 |
| Stage3-vs-Stage4 |
2.524200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80810000000231E-06 |
| Normal-vs-AfricanAmerican |
2.081800E-01 |
| Normal-vs-Asian |
1.175950E-03 |
| Caucasian-vs-AfricanAmerican |
1.309420E-01 |
| Caucasian-vs-Asian |
2.454800E-01 |
| AfricanAmerican-vs-Asian |
3.619600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.79060000000365E-05 |
| Normal-vs-Female |
4.45420000000363E-05 |
| Male-vs-Female |
9.264600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.366800E-04 |
| Normal-vs-Age(41-60Yrs) |
4.32540000000481E-05 |
| Normal-vs-Age(61-80Yrs) |
4.34339999999533E-06 |
| Normal-vs-Age(81-100Yrs) |
1.891650E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.960400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.193780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.987400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.589000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.746800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.981800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.525700E-02 |
| Classical-VS-Follicular |
7.190300E-02 |
| Classical-VS-Other |
9.211000E-01 |
| Classical-VS-Normal |
9.74240000000126E-05 |
| Tall-VS-Follicular |
7.832800E-04 |
| Tall-VS-Other |
1.723610E-01 |
| Tall-VS-Normal |
5.45729999967826E-07 |
| Follicular-VS-Other |
6.427000E-01 |
| Follicular-VS-Normal |
6.741400E-03 |
| Other-VS-Normal |
1.241360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6543E-05 |
| Normal-vs-N1 |
1.5080000004275E-07 |
| N0-vs-N1 |
3.141000E-03 |
|
|
